ARLINGTON, Va., Oct. 25, 2017 -- In the US, the life science workforce is aging. As older scientists retire they make room for newly trained scientist workers, who bring updated skills to the lab and new approaches to problem solving. The latest report from BioInformatics LLC explores how generational differences affect scientists’ receptiveness to a wide variety of techniques used to influence their laboratory purchasing decisions.
The report is based on a survey of more than 1,000 scientists and examines social media, executive branding, livestreaming, sponsored content, influencers, experiential and mobile marketing and their effectiveness in communicating with a scientific audience.
“By far, the most interesting and perhaps most actionable results can be viewed through the filter of age,” says Dr. Robin Rothrock, Vice President, Publications. “Our data suggests a demographic inflection point has been reached in the scientific population, and not just in North America. Boomers are retiring and Millennials are working their way through graduate school and beginning their careers in scientific research. These differences are reflected in how they want to interact with vendor-created content in addition to the nature of the content they want to consume.”
Through extensive, accurate survey data and detailed explanations of each channel, this report allows marketers to understand how life scientist customers interact with a variety of media channels, and how to deliver a consistent brand message to the right people using the most appropriate and effective touchpoints.
Download a free brochure with a detailed table of contents and some sample data by visiting the BioInformatics website.
Market reports from BioInformatics and SDI are unique in their combination of reliable market forecasts and actionable Voice of Customer survey data. The topics addressed include brand health, brand awareness, usage, market share, experimental workflow, customer satisfaction, switching behavior, spending plans, and more. Complimentary Executive Summaries can be downloaded from BioInformatics’ catalog.
ABOUT BIOINFORMATICS LLC
BioInformatics LLC and its SDi division form the premier research and advisory firm serving executives at companies developing scientific tools. Custom research offerings include assessing the size and attractiveness of scientific markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.
For more information contact: Devin Holland BioInformatics LLC 2111 Wilson Boulevard Suite 250 Arlington, VA 22201 Phone: 703.778.3080 x19 [email protected]


China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 



